John G. Curd

5.0k total citations · 1 hit paper
94 papers, 3.8k citations indexed

About

John G. Curd is a scholar working on Immunology, Genetics and Hematology. According to data from OpenAlex, John G. Curd has authored 94 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Immunology, 25 papers in Genetics and 19 papers in Hematology. Recurrent topics in John G. Curd's work include Complement system in diseases (21 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). John G. Curd is often cited by papers focused on Complement system in diseases (21 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). John G. Curd collaborates with scholars based in United States, Canada and France. John G. Curd's co-authors include Robert I. Fox, Charles A. Robinson, Franklin Kozin, Bruce L. Zuraw, Roger P. Thorne, Richard T. Ellison, Charles G. Cochrane, Michael Star, Peter F. Köhler and L. Barth Reller and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

John G. Curd

91 papers receiving 3.6k citations

Hit Papers

Sjögren's syndrome. Proposed criteria for classification 1986 2026 1999 2012 1986 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John G. Curd United States 37 875 756 703 702 677 94 3.8k
Lung T. Yam United States 35 1.1k 1.3× 565 0.7× 809 1.2× 314 0.4× 340 0.5× 116 4.0k
Conleth Feighery Ireland 32 1.3k 1.5× 442 0.6× 690 1.0× 537 0.8× 324 0.5× 125 3.7k
D K Peters United Kingdom 37 1.9k 2.2× 766 1.0× 839 1.2× 332 0.5× 562 0.8× 103 4.6k
A. V. Hoffbrand United Kingdom 40 547 0.6× 491 0.6× 1.4k 1.9× 707 1.0× 255 0.4× 101 4.6k
M Kazatchkine France 38 2.3k 2.6× 398 0.5× 556 0.8× 433 0.6× 383 0.6× 100 4.6k
Robert L. Vernier United States 44 551 0.6× 279 0.4× 559 0.8× 642 0.9× 282 0.4× 123 4.9k
D Émilie France 38 2.2k 2.5× 345 0.5× 1.0k 1.4× 690 1.0× 650 1.0× 92 5.5k
Clark D. West United States 38 1.7k 2.0× 645 0.9× 386 0.5× 284 0.4× 237 0.4× 138 3.9k
Jörgen Wieslander Sweden 43 1.2k 1.4× 1.5k 1.9× 913 1.3× 384 0.5× 527 0.8× 130 6.2k
Rodney Bluestone United States 35 1.2k 1.4× 1.2k 1.5× 3.0k 4.3× 589 0.8× 259 0.4× 155 5.4k

Countries citing papers authored by John G. Curd

Since Specialization
Citations

This map shows the geographic impact of John G. Curd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Curd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Curd more than expected).

Fields of papers citing papers by John G. Curd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Curd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Curd. The network helps show where John G. Curd may publish in the future.

Co-authorship network of co-authors of John G. Curd

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Curd. A scholar is included among the top collaborators of John G. Curd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Curd. John G. Curd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Jessica D., Qian Liu, Jingli Wang, et al.. (2011). Selective Tumor Hypoxia Targeting by Hypoxia-Activated Prodrug TH-302 Inhibits Tumor Growth in Preclinical Models of Cancer. Clinical Cancer Research. 18(3). 758–770. 142 indexed citations
2.
Zhang, Jinsong, Jun Li, Dongming Chen, et al.. (2009). Inhibition of Both Thioredoxin Reductase and Glutathione Reductase may Contribute to the Anticancer Mechanism of TH-302. Biological Trace Element Research. 136(3). 294–301. 20 indexed citations
3.
Peebles, Carol, et al.. (1991). Autoantibodies to native myeloperoxidase in patients with pulmonary hemorrhage and acute renal failure. Journal of Clinical Immunology. 11(6). 389–397. 17 indexed citations
4.
Ellison, Richard T., C. Robert Horsburgh, & John G. Curd. (1990). Complement levels in patients with hepatic dysfunction. Digestive Diseases and Sciences. 35(2). 231–235. 29 indexed citations
5.
Carrera, C J, Chihiro Terai, Martin Lotz, et al.. (1990). Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.. Journal of Clinical Investigation. 86(5). 1480–1488. 111 indexed citations
6.
Wyatt, Robert, et al.. (1988). Complement profiles in acute post-streptococcal glomerulonephritis. Pediatric Nephrology. 2(2). 219–223. 41 indexed citations
7.
Fox, R., Christopher P. Robinson, John G. Curd, et al.. (1986). First International Symposium on Sjögren’s Syndrome: Suggested Criteria for Classification. Scandinavian Journal of Rheumatology. 15(sup61). 28–30. 28 indexed citations
8.
Curd, John G., et al.. (1986). First international symposium on Sjögren's syndrome: suggested criteria for classification.. PubMed. 61. 28–30. 65 indexed citations
9.
Federici, Augusto B., et al.. (1984). Increased von willebrand factor antigen in the plasma of patients with vasculitis. Arthritis & Rheumatism. 27(12). 1405–1410. 73 indexed citations
10.
Beall, Gildon N., et al.. (1984). Studies of complement activation and IgG subclass restriction of anti-thyroglobulin.. PubMed. 56(2). 383–9. 14 indexed citations
11.
Vaughan, J H, et al.. (1984). Thoracic duct drainage in rheumatoid arthritis.. PubMed. 58(3). 645–53. 13 indexed citations
12.
Novey, Harold S., et al.. (1983). Postprandial exercise-induced anaphylaxis. Journal of Allergy and Clinical Immunology. 71(5). 498–504. 80 indexed citations
13.
Lasser, E. C., et al.. (1983). The plasma contact system in atopic asthma. Journal of Allergy and Clinical Immunology. 72(1). 83–88. 22 indexed citations
14.
Pizzo, C. J., et al.. (1983). Immunodiffusion Assay of C1 Inhibitor Function in Serum: Prospective Analysis in Angioedema-Urticaria. American Journal of Clinical Pathology. 80(3). 309–313. 2 indexed citations
15.
Harriman, Gregory R., et al.. (1982). Activation of complement by serum-resistant Neisseria gonorrhoeae. Assembly of the membrane attack complex without subsequent cell death.. The Journal of Experimental Medicine. 156(4). 1235–1249. 52 indexed citations
16.
Atkinson, John P., John G. Curd, Michael J. Deegan, et al.. (1981). Cold dependent activation of complement in systemic lupus erythematosus. Arthritis & Rheumatism. 24(4). 592–601. 17 indexed citations
17.
Harriman, Gregory R., A F Esser, Eckhard R. Podack, et al.. (1981). The role of C9 in complement-mediated killing of Neisseria.. The Journal of Immunology. 127(6). 2386–2390. 51 indexed citations
18.
Curd, John G., et al.. (1980). Detection of active kallikrein in induced blister fluids of hereditary angioedema patients.. The Journal of Experimental Medicine. 152(3). 742–747. 106 indexed citations
19.
Resnick, Donald, John G. Curd, Robert F. Shapiro, & Kenneth B. Wiesner. (1978). Radiographic abnormalities of rheumatoid arthritis in patients with diffuse idiopathic skeletal hyperostosis. Arthritis & Rheumatism. 21(1). 1–5. 25 indexed citations
20.
Curd, John G. & Neil R. Cooper. (1978). C1 Binding to Complexes Consisting of Cross-linked Fc Molecules from Human Immunoglobulin G. The Journal of Immunology. 120(5). 1769–1769. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026